Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Leukemia 17Breast Neoplasms 14Rectal Neoplasms 7Neoplastic Cells, Circulating 7Lung Neoplasms 7Leukemia, Myeloid, Acute 7Colorectal Neoplasms 7Colonic Neoplasms 7Prostatic Neoplasms 6Head and Neck Neoplasms 6Kidney Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Squamous Cell Carcinoma of Head and Neck 4Sarcoma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 4Congenital Abnormalities 4Wilms Tumor 3Neoplasms, Plasma Cell 3Carcinoma, Renal Cell 3Carcinoma, Intraductal, Noninfiltrating 3Unspecified Adult Solid Tumor, Protocol Specific 2Ovarian Neoplasms 2Melanoma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Esophageal Neoplasms 2Endometrial Neoplasms 2

Interventions

thymoglobulin 1selinexor 1fludarabine 1Rituximab 1Reverse Transcriptase Polymerase Chain Reaction 1Panobinostat 1Melphalan 1Levetiracetam 1Daunorubicin 1Cytarabine 1Cyclophosphamide 1Busulfan 1Bronchoalveolar Lavage 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chromosome Aberrations × Reverse Transcriptase Polymerase Chain Reaction × Clear all
NCT00280202 2025-10-24

Detection of Genetic Markers of Lung Cancer

University of Pittsburgh

Recruiting
6,000 enrolled
Thoracic

Chromosome Aberrations, Lung Neoplasms, Carcinogenesis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡